Regeneron Pharmaceuticals Inc REGN:NASDAQ

Last Price$399.14NASDAQ Previous Close - Last Trade as of 4:00PM ET 2/20/20

Today's Change-1.67(0.42%)
Bid (Size)$390.16 (1)
Ask (Size)$405.00 (1)
Day Low / High$393.76 - 401.09
Volume660.8 K

Regeneron Pharmaceuticals Tops Q2 Non-GAAP EPS, Revenue Estimates

2:02PM ET 8/06/2019 MT Newswires
Regeneron Pharmaceuticals (REGN) said Tuesday hat its Q2 non-GAAP net income was $690 million, or $6.02 per diluted share, improving year over year from $624 million, or $5.45 per diluted share, and beating estimates compiled by Capital IQ for $5.42 per share.

The company also booked a 20% increase in revenue to $1.93 billion, exceeding consensus of $1.8 billion.

Price: 300.36, Change: +0.79, Percent Change: +0.26